ENBIO HOLDINGS, INC Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Summary of Consolidated Financial Results for the Six Months Ended September 30 2021 (Based on Japanese GAAP)
Novembert 12, 2021 | ||||
Company name: | Enbio Holdings, Inc | |||
Listing: | Tokyo | |||
Stock code: | 6092 | URL: https://www.enbio-holdings.com | ||
Representative: | President & Chief Operating Officer | Minoru Nishimura | ||
Inquiries: | Accounting Director | Takaharu Hasegawa | TEL:03-5297-7155 | |
Scheduled date to file Quarterly Securities Report: | November 12, 2021 | |||
Scheduled date to commence dividend payments: | - | |||
Preparation of supplementary material on quarterly financial results: | No | |||
Holding of quarterly financial results briefing: | No |
(Amounts less than one million yen are rounded down)
1. Consolidated financial results for the six months ended September 30, 2021 (from April 1 to September 30, 2021)
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | |||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||||||||||||
owners of parent | ||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||
Six months ended September 30, 2021 | 4,301 | 18.8 | 702 | 71.2 | 674 | 76.1 | 375 | 42.3 | ||||||||||
Six months ended September 30, 2020 | 3,621 | (15.5) | 410 | (34.5) | 382 | (26.2) | 263 | (49.6) | ||||||||||
(Note) Comprehensive income: | Six months ended September 30, 2021 : 352 millions of yen 13.1% | |||||||||||||||||
Six months ended September 30, 2020 : 311 millions of yen (39.9%) | ||||||||||||||||||
Basic earnings | Diluted earnings | |||||||||||||||||
per share | per share | |||||||||||||||||
Yen | Yen | |||||||||||||||||
Six months ended September 30, 2021 | 56.62 | 56.58 | ||||||||||||||||
Six months ended September 30, 2020 | 40.15 | 39.73 | ||||||||||||||||
(2) Consolidated financial position | ||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||||
Millions of yen | Millions of yen | % | Yen | |||||||||||||||
As of September 30, 2021 | 15,863 | 5,614 | 35.2 | 840.34 | ||||||||||||||
As of March 31, 2021 | 15,698 | 5,317 | 33.7 | 795.22 | ||||||||||||||
(Reference) Equity: | As of September 30, 2021: 5,586 millions of yen | |||||||||||||||||
As of March 31, 2021 : 5,286 millions of yen | ||||||||||||||||||
2. Cash dividends | ||||||||||||||||||
Annual dividends per share | ||||||||||||||||||
First quarter-end | Second quarter-end | Third quarter-end | Fiscal year-end | Total | ||||||||||||||
Yen | Yen | Yen | Yen | Yen | ||||||||||||||
Year ended March 31, 2021 | - | 0.00 | - | 0.00 | 0.00 | |||||||||||||
Year ending March 31, 2022 | - | |||||||||||||||||
Year ending March 31 2022 (Forecast) | 0.00 | - | 0.00 | 0.00 | ||||||||||||||
(Note) Revisions to the forecast of cash dividends most recently announced: No
3. Forecast of consolidated financial results for the year ending March 31, 2022 (from April 1 2021 to March 31, 2022)
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | |||||||
owners of parent | |||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |||
Full year | 8,550 | 25.0 | 749 | 21.3 | 645 | 8.9 | 361 | 18.8 | 54.44 | ||
(Note) Revisions to the financial results forecast most recently announced: No | |||||||||||
4. Notes | |||||||||||
(1) Changes in significant subsidiaries during the Six months ended September 30, 2021 | |||||||||||
(changes in specified subsidiaries resulting in the change in scope of consolidation): | No | ||||||||||
(2) Application of special accounting methods for preparing quarterly consolidated financial statements: | No | ||||||||||
(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |||||||||||
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes | ||||||||||
Changes in accounting policies due to other reasons: | No | ||||||||||
Changes in accounting estimates; | No | ||||||||||
Restatement of prior period financial statements | No |
(4) Number of issued shares (common shares)
Total number of issue shares at the end of the period (including treasury shares)
As of September 30, 2021 | 6,671,700 shares | As of March 31, 2021 | 6,648,700 shares |
Number of treasury shares at the end of the period | |||
As of September 30, 2021 | 24,309 shares | As of March 31, 2021 | 1,109 shares |
Average number of shares during the period (cumulative from the beginning of the fiscal year)
As of September 30, 2021 | 6,632,248 shares | As of September 30, 2020 | 6,571,381 shares |
Quarterly consolidated financial statements
Consolidated balance sheets
(Thousands of yen) | ||
As of March 31, 2021 | As of September 30, 2021 | |
Assets | ||
Current assets | ||
Cash and deposits | 2,015,310 | 3,139,580 |
Notes and accounts receivable - trade | 978,524 | - |
Notes and accounts receivable - trade, and contract assets | - | 743,586 |
Inventories | 3,119,353 | 2,261,730 |
Other | 533,042 | 593,930 |
Allowance for doubtful accounts | (30,538) | (23,926) |
Total current assets | 6,615,693 | 6,714,901 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings and structures, net | 440,667 | 482,201 |
Machinery, equipment and vehicles, net | 3,891,678 | 3,868,242 |
Land | 2,852,880 | 2,952,182 |
Construction in progress | 143,119 | 96,778 |
Other, net | 3,877 | 6,969 |
Total property, plant and equipment | 7,332,223 | 7,406,374 |
Intangible assets | ||
Goodwill | 126,098 | 122,094 |
Other | 454,186 | 440,368 |
Total intangible assets | 580,285 | 562,463 |
Investments and other assets | 1,167,814 | 1,179,027 |
Total non-current assets | 9,080,322 | 9,147,866 |
Deferred assets | 2,564 | 1,025 |
Total assets | 15,698,580 | 15,863,793 |
Liabilities | ||
Current liabilities | ||
Accounts payable - trade | 542,705 | 654,984 |
Accounts payable - other, and accrued expenses | 52,487 | 75,502 |
Short-term borrowings | 955,300 | 667,000 |
Current portion of long-term borrowings | 1,050,209 | 1,596,590 |
Income taxes payable | 20,995 | 177,348 |
Provision for loss on construction contracts | - | 2,762 |
Other | 406,317 | 346,142 |
Total current liabilities | 3,028,014 | 3,520 330 |
Non-current liabilities | ||
Bonds payable | 71,500 | 54,000 |
Long-term borrowings | 6,959,732 | 6,347,124 |
Asset retirement obligations | 89,957 | 99,367 |
Derivatives liabilities | 182,905 | 187, 791 |
Other | 49,290 | 40,241 |
Total non-current liabilities | 7,353,385 | 6,728,524 |
Total liabilities | 10,381,400 | 10,248 855 |
(Thousands of yen) | ||
As of March 31, 2021 | As of September 30, 2021 | |
Net assets | ||
Shareholders' equity | ||
Share capital | 1,794,509 | 1,796,809 |
Capital surplus | 1,873,093 | 1,876,049 |
Retained earnings | 1,743,576 | 2,074,749 |
Treasury shares | (96) | (15,396) |
Total shareholders' equity | 5,411,081 | 5,732,211 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 46,728 | (7,929) |
Deferred gains or losses on hedges | (135,181) | (139,543) |
Foreign currency translation adjustment | (36,329) | 1,362 |
Total accumulated other comprehensive income | (124,781) | (146,110) |
Share acquisition rights | 304 | - |
Non-controlling interests | 30,575 | 28,836 |
Total net assets | 5,317,179 | 5,614,937 |
Total liabilities and net assets | 15,698,580 | 15,863,793 |
Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income (For the six months)
(Thousands of yen) | ||
Six months ended | Six months ended | |
September 30, 2020 | September 30, 2021 | |
Net sales | 3,621,354 | 4,301,517 |
Cost of sales | 2,583,528 | 3,009,814 |
Gross profit | 1,037,825 | 1,291,703 |
Selling, general and administrative expenses | 627,319 | 588,823 |
Operating profit | 410,505 | 702,880 |
Non-operating income | ||
Interest and dividend income | 8,287 | 35,949 |
Reversal of allowance for doubtful accounts | - | 6,612 |
Rental income from buildings | 2,503 | 2,503 |
Insurance claim income | 56,478 | 582 |
Other | 10,326 | 16,787 |
Total non-operating income | 77,595 | 62,435 |
Non-operating expenses | ||
Interest expenses | 62,083 | 63,981 |
Commission expenses | 27,851 | 24,929 |
Other | 15,374 | 2,352 |
Total non-operating expenses | 105,309 | 91,263 |
Ordinary profit | 382,792 | 674,052 |
Extraordinary income | ||
Gain on sale of non-current assets | 11,899 | - |
Gain on reversal of share acquisition rights | - | 304 |
Total extraordinary income | 11,899 | 304 |
Extraordinary losses | ||
Impairment losses | - | 91,498 |
Loss on retirement of non-current assets | - | 1,532 |
Total extraordinary losses | - | 93,031 |
Profit before income taxes | 394,692 | 581,325 |
Income taxes - current | 76,611 | 201,835 |
Income taxes - deferred | 29,993 | 6,204 |
Total income taxes | 106,604 | 208,040 |
Profit | 288,087 | 373,285 |
Profit (loss) attributable to non-controlling interests | 24,236 | (2,254) |
Profit attributable to owners of parent | 263,850 | 375,540 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Enbio Holdings Inc. published this content on 19 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 November 2021 04:32:03 UTC.
